代谢综合征对病态肥胖患者初次全膝关节置换术并发症与假体生存率的影响
本研究回顾性纳入单学术机构因病态肥胖(BMI>40)接受初次全膝关节置换术的骨关节炎患者,将合并与不合并代谢综合征者按基线特征1:1倾向性匹配。结果显示代谢综合征组住院时间更长、转至专业护理机构比例更高,但90天并发症、再入院、翻修率及患者报告结局无显著差异。
要点
- 代谢综合征组住院时间3.5±2.4天 vs 非代谢综合征组3.0±1.5天(P=.001)。
- 代谢综合征组转专业护理机构比例23.8% vs 15.3%(P=.007)。
- 90天主要和次要并发症、再入院、翻修率及KOOS-JR与VR-12评分改善两组无显著差异。
核心结论
- 病态肥胖合并代谢综合征患者初次全膝关节置换术后住院时间更长、转专业护理机构比例更高,但90天并发症、再入院、翻修率及患者报告结局与不合并代谢综合征者相似。
- 作者认为资源分配应侧重于围手术期方案,以帮助优化病态肥胖代谢综合征患者接受全膝关节置换术的住院时间和出院去向。
研究设计与样本
- 回顾性综述,纳入单学术机构所有因病态肥胖(体重指数>40)因骨关节炎接受初次择期全膝关节置换术的患者。
- 合并与不合并代谢综合征的患者按基线特征进行1:1倾向性匹配。
- 共纳入391例合并代谢综合征患者和935例不合并代谢综合征患者,平均体重指数44.2(范围40.0至68.9)。
- 证据等级III。
主要发现
- 代谢综合征组住院时间3.5±2.4天 vs 非代谢综合征组3.0±1.5天(P=.001)。
- 代谢综合征组转专业护理机构比例23.8% vs 非代谢综合征组15.3%(P=.007)。
- 术后90天主要并发症率(P=.756)、次要并发症率(P=.652)和再入院率(P=.359)两组相似。
- 翻修率以及KOOS-JR、VR-12心理和生理组分评分从术前至术后1年的改善两组无显著差异(P分别为.856、.524和.727)。
- 代谢综合征与非代谢综合征患者5年无全因翻修生存率相似(90.2% vs 94.2%,P=.791)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Metabolic syndrome (MetS) includes interrelated conditions such as insulin resistance, abdominal obesity, hypertension, and dyslipidemia. This study sought to determine the association of MetS in morbidly obese patients (body mass index >40) on complications and clinical outcomes after primary total knee arthroplasty (TKA). METHODS: A retrospective review was performed to include all morbidly obese patients who underwent primary elective TKA for osteoarthritis at a single academic institution. Patients who did and did not have MetS were propensity-matched 1:1 based on baseline characteristics. A total of 391 patients who did and 935 who did not have MetS were included having a mean body mass index of 44.2 (range, 40.0 to 68.9). RESULTS: The MetS patients had longer lengths of stay (LOS) (3.5 ± 2.4 versus 3.0 ± 1.5 days, P = .001) and were more likely to be discharged to skilled nursing facilities (23.8 versus 15.3%, P = .007). At 90 days postoperatively, major (P = .756) and minor (P = .652) complication rates and readmissions (P = .359) were similar. Revision rates as well as improvements in KOOS-JR, and VR-12 mental and physical component scores from preoperative to 1 year (P = .856, P = .524, and P = .727, respectively) postoperatively did not significantly differ between groups. MetS and non-MetS patients had similar 5-year freedom from all-cause revision (90.2 versus 94.2%, P = .791). CONCLUSION: Morbidly obese patients who have MetS had longer LOS and higher discharges to skilled nursing facilities. The 90-day complications, readmissions, revision rates, and patient-reported outcomes were similar, suggesting that resource allocation should be focused on perioperative protocols that can help optimize LOS and discharge dispositions in morbidly obese MetS patients undergoing TKA. LEVEL OF EVIDENCE: III.
引用
- Shichman I, Oakley CT, Konopka JA, et al. The Association of Metabolic Syndrome on Complications and Implant Survivorship in Primary Total Knee Arthroplasty in Morbidly Obese Patients. J Arthroplasty. 2022. PMID: 36572234. doi:10.1016/j.arth.2022.12.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。